20485543|t|Reduction of circulating endothelial cells in peripheral blood of ALS patients.
20485543|a|BACKGROUND: Amyotrophic Lateral Sclerosis (ALS) treatment is complicated by the various mechanisms underlying motor neuron degeneration. Recent studies showed that the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) are compromised in an animal model of ALS due to endothelial cell degeneration. A later study demonstrated a loss of endothelium integrity in the spinal cords of ALS patients. Since circulating endothelial cells (CECs) in the peripheral blood are associated with endothelium damage, being detached dysfunctional endothelial cells, we hypothesized that CEC levels may reflect endothelium condition in ALS patients. METHODOLOGY/PRINCIPAL FINDINGS: CEC levels were estimated in whole blood smears from ALS patients with moderate stage ((M)ALS), severe stage ((S)ALS), and healthy controls by CD146 expression using immunocytochemistry. A significant reduction of CECs was detected in (M)ALS and (S)ALS patients. CONCLUSIONS/SIGNIFICANCE: CECs did not predict endothelium state in ALS patients; however, endothelial damage and/or impaired endothelium repair may occur in ALS leading to BBB/BSCB dysfunction. Reduced CECs in peripheral blood of ALS patients may indicate different mechanisms of endothelial damage and repair, rather than only detachment of dysfunctional endothelial cells. Although a potential mechanism of CEC reduction is discussed, establishing a reliable indicator of endothelial dysfunction/damage is important for evaluation of BBB/BSCB status in ALS patients during disease progression.
20485543	66	69	ALS	Disease	MESH:D000690
20485543	70	78	patients	Species	9606
20485543	92	121	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
20485543	123	126	ALS	Disease	MESH:D000690
20485543	190	215	motor neuron degeneration	Disease	MESH:D009410
20485543	349	352	ALS	Disease	MESH:D000690
20485543	360	389	endothelial cell degeneration	Disease	MESH:D055954
20485543	473	476	ALS	Disease	MESH:D000690
20485543	477	485	patients	Species	9606
20485543	711	714	ALS	Disease	MESH:D000690
20485543	715	723	patients	Species	9606
20485543	810	813	ALS	Disease	MESH:D000690
20485543	814	822	patients	Species	9606
20485543	847	850	ALS	Disease	MESH:D000690
20485543	870	873	ALS	Disease	MESH:D000690
20485543	900	905	CD146	Gene	4162
20485543	995	998	ALS	Disease	MESH:D000690
20485543	1006	1009	ALS	Disease	MESH:D000690
20485543	1010	1018	patients	Species	9606
20485543	1088	1091	ALS	Disease	MESH:D000690
20485543	1092	1100	patients	Species	9606
20485543	1178	1181	ALS	Disease	MESH:D000690
20485543	1202	1213	dysfunction	Disease	MESH:D006331
20485543	1251	1254	ALS	Disease	MESH:D000690
20485543	1255	1263	patients	Species	9606
20485543	1507	1518	dysfunction	Disease	MESH:D006331
20485543	1576	1579	ALS	Disease	MESH:D000690
20485543	1580	1588	patients	Species	9606

